ARS Pharmaceuticals' Neffy Launch Could Be A Hit For Severe Allergic Reactions
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.
Livestrong.com on MSN16h
Phenylephrine for Colds: Why It Doesn’t Work and What You Should Use Instead
Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...
Drug Store News17h
Lupin receives FDA nod for generic Atrovent
Ipratropium bromide nasal solution 0.06% is indicated for symptomatic relief of rhinorrhea associated with the common cold or ...